Skip to main content
Article
A review of black salve: cancer specificity, cure and cosmesis
Evidence-Based Complementary and Alternative Medicine
  • Andrew Croaker, Southern Cross University
  • Graham J King, Southern Cross University
  • John Pyne, University of Queensland
  • Shailendra Anoopkumar-Dukie, Griffith University
  • Lei Liu, Southern Cross University
Document Type
Article
Publication Date
1-1-2017
Peer Reviewed
Peer-Reviewed
Abstract
Black salve is a topical escharotic used for the treatment of skin cancer. Although promoted as a safe and effective alternative to conventional management by its proponents, limited clinical research has been undertaken to assess its efficacy and potential toxicities. Patients are increasingly utilizing the Internet as a source of health information. As a minimally regulated space, the quality and accuracy of this information vary considerably. This review explores four health claims made by black salve vendors, investigating its natural therapy credentials, tumour specificity, and equivalence to orthodox medicine in relation to skin cancer cure rates and cosmesis. Based upon an analysis of in vitro constituent cytotoxicity, in vivo post black salve histology, and experience with Mohs paste, black salve is likely to possess normal tissue toxicity with some cancer cell lines being relatively resistant to its effects. This may explain the incongruous case study reports of excessive scarring, deformity, and treatment failure.
Disciplines
Citation Information

Croaker, A, King, GJ, Pyne, JH, Anoopkumar-Dukie, S & Liu, L 2017, 'A review of black salve: cancer specificity, cure and cosmesis', Evidence-Based Complementary and Alternative Medicine, vol. 2017, art. 9184034.

Article available on Open Access